Recently, several studies demonstrated characteristic histopathological alterations in esophageal mucosa of patients with GERD and a proinflammatory response including the activation of related pathways such as NFκB, PAR-2, ROS and iNOS[50,51]. The gene discussed is F2RL1; the disease is gastroesophageal reflux disease.